Global Biodegradable Embolic Microspheres Industry Growth and Trends Forecast to 2031

Summary

According to APO Research, The global Biodegradable Embolic Microspheres market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Biodegradable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Biodegradable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Biodegradable Embolic Microspheres is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Biodegradable Embolic Microspheres include Varian, Jiangsu Hengrui Medicine, Terumo Corporation, Tepha, Teleflex, Promedics AG, Occlugel, Nippon Kayaku and Next Biomedical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biodegradable Embolic Microspheres, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biodegradable Embolic Microspheres.

The Biodegradable Embolic Microspheres market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biodegradable Embolic Microspheres market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Biodegradable Embolic Microspheres Segment by Company

Varian
Jiangsu Hengrui Medicine
Terumo Corporation
Tepha
Teleflex
Promedics AG
Occlugel
Nippon Kayaku
Next Biomedical
Mermaid Medical
Merit Medical Systems
CeloNova BioSciences
BTG Corporate
Biosphere Medical
Biocompatibles
Angio Dynamics
ABK Biomedical

Biodegradable Embolic Microspheres Segment by Type

Visualization Type
Environmentally Responsive Type
Radioactive Type
Other

Biodegradable Embolic Microspheres Segment by Application

Research Institution
Hospitals And Clinics

Biodegradable Embolic Microspheres Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Embolic Microspheres.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biodegradable Embolic Microspheres manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Biodegradable Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview

1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Biodegradable Embolic Microspheres Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Biodegradable Embolic Microspheres Sales Estimates and Forecasts (2020-2031)
1.3 Biodegradable Embolic Microspheres Market by Type
1.3.1 Visualization Type
1.3.2 Environmentally Responsive Type
1.3.3 Radioactive Type
1.3.4 Other
1.4 Global Biodegradable Embolic Microspheres Market Size by Type
1.4.1 Global Biodegradable Embolic Microspheres Market Size Overview by Type (2020-2031)
1.4.2 Global Biodegradable Embolic Microspheres Historic Market Size Review by Type (2020-2025)
1.4.3 Global Biodegradable Embolic Microspheres Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Biodegradable Embolic Microspheres Sales Breakdown by Type (2020-2025)
1.5.2 Europe Biodegradable Embolic Microspheres Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Biodegradable Embolic Microspheres Sales Breakdown by Type (2020-2025)
1.5.4 South America Biodegradable Embolic Microspheres Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Biodegradable Embolic Microspheres Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics

2.1 Biodegradable Embolic Microspheres Industry Trends
2.2 Biodegradable Embolic Microspheres Industry Drivers
2.3 Biodegradable Embolic Microspheres Industry Opportunities and Challenges
2.4 Biodegradable Embolic Microspheres Industry Restraints
3 Market Competitive Landscape by Company

3.1 Global Top Players by Biodegradable Embolic Microspheres Revenue (2020-2025)
3.2 Global Top Players by Biodegradable Embolic Microspheres Sales (2020-2025)
3.3 Global Top Players by Biodegradable Embolic Microspheres Price (2020-2025)
3.4 Global Biodegradable Embolic Microspheres Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Biodegradable Embolic Microspheres Major Company Production Sites & Headquarters
3.6 Global Biodegradable Embolic Microspheres Company, Product Type & Application
3.7 Global Biodegradable Embolic Microspheres Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Biodegradable Embolic Microspheres Market CR5 and HHI
3.8.2 Global Top 5 and 10 Biodegradable Embolic Microspheres Players Market Share by Revenue in 2024
3.8.3 2023 Biodegradable Embolic Microspheres Tier 1, Tier 2, and Tier 3
4 Biodegradable Embolic Microspheres Regional Status and Outlook

4.1 Global Biodegradable Embolic Microspheres Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Biodegradable Embolic Microspheres Historic Market Size by Region
4.2.1 Global Biodegradable Embolic Microspheres Sales in Volume by Region (2020-2025)
4.2.2 Global Biodegradable Embolic Microspheres Sales in Value by Region (2020-2025)
4.2.3 Global Biodegradable Embolic Microspheres Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Biodegradable Embolic Microspheres Forecasted Market Size by Region
4.3.1 Global Biodegradable Embolic Microspheres Sales in Volume by Region (2026-2031)
4.3.2 Global Biodegradable Embolic Microspheres Sales in Value by Region (2026-2031)
4.3.3 Global Biodegradable Embolic Microspheres Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Biodegradable Embolic Microspheres by Application

5.1 Biodegradable Embolic Microspheres Market by Application
5.1.1 Research Institution
5.1.2 Hospitals And Clinics
5.2 Global Biodegradable Embolic Microspheres Market Size by Application
5.2.1 Global Biodegradable Embolic Microspheres Market Size Overview by Application (2020-2031)
5.2.2 Global Biodegradable Embolic Microspheres Historic Market Size Review by Application (2020-2025)
5.2.3 Global Biodegradable Embolic Microspheres Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Biodegradable Embolic Microspheres Sales Breakdown by Application (2020-2025)
5.3.2 Europe Biodegradable Embolic Microspheres Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Biodegradable Embolic Microspheres Sales Breakdown by Application (2020-2025)
5.3.4 South America Biodegradable Embolic Microspheres Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Biodegradable Embolic Microspheres Sales Breakdown by Application (2020-2025)
6 Company Profiles

6.1 Varian
6.1.1 Varian Comapny Information
6.1.2 Varian Business Overview
6.1.3 Varian Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Varian Biodegradable Embolic Microspheres Product Portfolio
6.1.5 Varian Recent Developments
6.2 Jiangsu Hengrui Medicine
6.2.1 Jiangsu Hengrui Medicine Comapny Information
6.2.2 Jiangsu Hengrui Medicine Business Overview
6.2.3 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Jiangsu Hengrui Medicine Biodegradable Embolic Microspheres Product Portfolio
6.2.5 Jiangsu Hengrui Medicine Recent Developments
6.3 Terumo Corporation
6.3.1 Terumo Corporation Comapny Information
6.3.2 Terumo Corporation Business Overview
6.3.3 Terumo Corporation Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Terumo Corporation Biodegradable Embolic Microspheres Product Portfolio
6.3.5 Terumo Corporation Recent Developments
6.4 Tepha
6.4.1 Tepha Comapny Information
6.4.2 Tepha Business Overview
6.4.3 Tepha Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Tepha Biodegradable Embolic Microspheres Product Portfolio
6.4.5 Tepha Recent Developments
6.5 Teleflex
6.5.1 Teleflex Comapny Information
6.5.2 Teleflex Business Overview
6.5.3 Teleflex Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teleflex Biodegradable Embolic Microspheres Product Portfolio
6.5.5 Teleflex Recent Developments
6.6 Promedics AG
6.6.1 Promedics AG Comapny Information
6.6.2 Promedics AG Business Overview
6.6.3 Promedics AG Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Promedics AG Biodegradable Embolic Microspheres Product Portfolio
6.6.5 Promedics AG Recent Developments
6.7 Occlugel
6.7.1 Occlugel Comapny Information
6.7.2 Occlugel Business Overview
6.7.3 Occlugel Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Occlugel Biodegradable Embolic Microspheres Product Portfolio
6.7.5 Occlugel Recent Developments
6.8 Nippon Kayaku
6.8.1 Nippon Kayaku Comapny Information
6.8.2 Nippon Kayaku Business Overview
6.8.3 Nippon Kayaku Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nippon Kayaku Biodegradable Embolic Microspheres Product Portfolio
6.8.5 Nippon Kayaku Recent Developments
6.9 Next Biomedical
6.9.1 Next Biomedical Comapny Information
6.9.2 Next Biomedical Business Overview
6.9.3 Next Biomedical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Next Biomedical Biodegradable Embolic Microspheres Product Portfolio
6.9.5 Next Biomedical Recent Developments
6.10 Mermaid Medical
6.10.1 Mermaid Medical Comapny Information
6.10.2 Mermaid Medical Business Overview
6.10.3 Mermaid Medical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Mermaid Medical Biodegradable Embolic Microspheres Product Portfolio
6.10.5 Mermaid Medical Recent Developments
6.11 Merit Medical Systems
6.11.1 Merit Medical Systems Comapny Information
6.11.2 Merit Medical Systems Business Overview
6.11.3 Merit Medical Systems Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Merit Medical Systems Biodegradable Embolic Microspheres Product Portfolio
6.11.5 Merit Medical Systems Recent Developments
6.12 CeloNova BioSciences
6.12.1 CeloNova BioSciences Comapny Information
6.12.2 CeloNova BioSciences Business Overview
6.12.3 CeloNova BioSciences Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.12.4 CeloNova BioSciences Biodegradable Embolic Microspheres Product Portfolio
6.12.5 CeloNova BioSciences Recent Developments
6.13 BTG Corporate
6.13.1 BTG Corporate Comapny Information
6.13.2 BTG Corporate Business Overview
6.13.3 BTG Corporate Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.13.4 BTG Corporate Biodegradable Embolic Microspheres Product Portfolio
6.13.5 BTG Corporate Recent Developments
6.14 Biosphere Medical
6.14.1 Biosphere Medical Comapny Information
6.14.2 Biosphere Medical Business Overview
6.14.3 Biosphere Medical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Biosphere Medical Biodegradable Embolic Microspheres Product Portfolio
6.14.5 Biosphere Medical Recent Developments
6.15 Biocompatibles
6.15.1 Biocompatibles Comapny Information
6.15.2 Biocompatibles Business Overview
6.15.3 Biocompatibles Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Biocompatibles Biodegradable Embolic Microspheres Product Portfolio
6.15.5 Biocompatibles Recent Developments
6.16 Angio Dynamics
6.16.1 Angio Dynamics Comapny Information
6.16.2 Angio Dynamics Business Overview
6.16.3 Angio Dynamics Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Angio Dynamics Biodegradable Embolic Microspheres Product Portfolio
6.16.5 Angio Dynamics Recent Developments
6.17 ABK Biomedical
6.17.1 ABK Biomedical Comapny Information
6.17.2 ABK Biomedical Business Overview
6.17.3 ABK Biomedical Biodegradable Embolic Microspheres Sales, Revenue and Gross Margin (2020-2025)
6.17.4 ABK Biomedical Biodegradable Embolic Microspheres Product Portfolio
6.17.5 ABK Biomedical Recent Developments
7 North America by Country

7.1 North America Biodegradable Embolic Microspheres Sales by Country
7.1.1 North America Biodegradable Embolic Microspheres Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Biodegradable Embolic Microspheres Sales by Country (2020-2025)
7.1.3 North America Biodegradable Embolic Microspheres Sales Forecast by Country (2026-2031)
7.2 North America Biodegradable Embolic Microspheres Market Size by Country
7.2.1 North America Biodegradable Embolic Microspheres Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Biodegradable Embolic Microspheres Market Size by Country (2020-2025)
7.2.3 North America Biodegradable Embolic Microspheres Market Size Forecast by Country (2026-2031)
8 Europe by Country

8.1 Europe Biodegradable Embolic Microspheres Sales by Country
8.1.1 Europe Biodegradable Embolic Microspheres Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Biodegradable Embolic Microspheres Sales by Country (2020-2025)
8.1.3 Europe Biodegradable Embolic Microspheres Sales Forecast by Country (2026-2031)
8.2 Europe Biodegradable Embolic Microspheres Market Size by Country
8.2.1 Europe Biodegradable Embolic Microspheres Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Biodegradable Embolic Microspheres Market Size by Country (2020-2025)
8.2.3 Europe Biodegradable Embolic Microspheres Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country

9.1 Asia-Pacific Biodegradable Embolic Microspheres Sales by Country
9.1.1 Asia-Pacific Biodegradable Embolic Microspheres Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Biodegradable Embolic Microspheres Sales by Country (2020-2025)
9.1.3 Asia-Pacific Biodegradable Embolic Microspheres Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Biodegradable Embolic Microspheres Market Size by Country
9.2.1 Asia-Pacific Biodegradable Embolic Microspheres Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Biodegradable Embolic Microspheres Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Biodegradable Embolic Microspheres Market Size Forecast by Country (2026-2031)
10 South America by Country

10.1 South America Biodegradable Embolic Microspheres Sales by Country
10.1.1 South America Biodegradable Embolic Microspheres Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Biodegradable Embolic Microspheres Sales by Country (2020-2025)
10.1.3 South America Biodegradable Embolic Microspheres Sales Forecast by Country (2026-2031)
10.2 South America Biodegradable Embolic Microspheres Market Size by Country
10.2.1 South America Biodegradable Embolic Microspheres Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Biodegradable Embolic Microspheres Market Size by Country (2020-2025)
10.2.3 South America Biodegradable Embolic Microspheres Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country

11.1 Middle East and Africa Biodegradable Embolic Microspheres Sales by Country
11.1.1 Middle East and Africa Biodegradable Embolic Microspheres Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Biodegradable Embolic Microspheres Sales by Country (2020-2025)
11.1.3 Middle East and Africa Biodegradable Embolic Microspheres Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Biodegradable Embolic Microspheres Market Size by Country
11.2.1 Middle East and Africa Biodegradable Embolic Microspheres Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Biodegradable Embolic Microspheres Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Biodegradable Embolic Microspheres Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis

12.1 Biodegradable Embolic Microspheres Value Chain Analysis
12.1.1 Biodegradable Embolic Microspheres Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Biodegradable Embolic Microspheres Production Mode & Process
12.2 Biodegradable Embolic Microspheres Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Biodegradable Embolic Microspheres Distributors
12.2.3 Biodegradable Embolic Microspheres Customers
13 Concluding Insights
14 Appendix

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings